Todd A. Braciak

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells.

Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells.

Journal: Oncoimmunology
Published: February 20, 2018

MicroRNA-192-5p is a predictive biomarker of survival for Stage IIIB colon cancer patients.

MicroRNA-192-5p is a predictive biomarker of survival for Stage IIIB colon cancer patients.

Journal: Japanese journal of clinical oncology
Published: June 05, 2017

Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival.

Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival.

Journal: PloS one
Published: March 19, 2017

Evidence for an Association of ERCC1 Expression and Mismatch Repair Status with Overall Survival in Colorectal Cancer Patients.

Evidence for an Association of ERCC1 Expression and Mismatch Repair Status with Overall Survival in Colorectal Cancer Patients.

Journal: Oncology research and treatment
Published: November 03, 2016

Impact of age and mismatch repair status on survival in colorectal cancer.

Impact of age and mismatch repair status on survival in colorectal cancer.

Journal: Cancer medicine
Published: September 19, 2016

A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.

A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.

Journal: PloS one
Published: September 05, 2016

Association between Ki67 Index and Clinicopathological Features in Colorectal Cancer.

Association between Ki67 Index and Clinicopathological Features in Colorectal Cancer.

Journal: Oncology research and treatment
Published: July 21, 2016

CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells.

CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells.

Journal: Oncotarget
Published: June 30, 2016

Chip-based platform for dynamic analysis of NK cell cytolysis mediated by a triplebody.

Chip-based platform for dynamic analysis of NK cell cytolysis mediated by a triplebody.

Journal: The Analyst
Published: March 10, 2016

Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19+ CD33+ leukemia cells.

Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19+ CD33+ leukemia cells.

Journal: Oncotarget
Published: November 11, 2015

T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cell.

T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cell.

Journal: Oncotarget
Published: August 14, 2014

Phage idiotype vaccination: first phase I/II clinical trial in patients with multiple myeloma.

Phage idiotype vaccination: first phase I/II clinical trial in patients with multiple myeloma.

Journal: Journal of translational medicine
Published: February 13, 2014
Showing 1-12 of 14

Last Updated: 09/26/2026